NDC 52959-457 - Gabazolamine-0.5
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 52959-457
- Package NDCs from labels
- 52959-457-30
- Manufacturer
- Physician Therapeutics LLC | Sandoz Inc | H.J. Harkins Company, Inc | Targeted Medical Pharma Inc.
- Effective date
- 2011-08-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabazolamine-0.5 | Physician Therapeutics LLC | Sandoz Inc | H.J. Harkins Company, Inc | Targeted Medical Pharma Inc. | 2011-08-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52959-457-30 | Gabazolamine-0.5 | 30 in 1 BOTTLE | TABLET | 30 | 0.5 mg | 8 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Stool Softener Regular Strength | DOCUSATE SODIUM | Sam's West, Inc | 1eca5910-b0bf-4e07-8211-36dba52b3de7 | 2026-01-06 | Warnings | F05Q2T2JA0 |
| Senna S | DOCUSATE SODIUM, SENNOSIDES | Safeway, Inc. | acb40b29-5fd5-4864-b6bf-4102e47a1683 | 2026-01-05 | Warnings | F05Q2T2JA0 |
| Senna-S | SENNOSIDES AND DOCUSATE SODIUM | RMT HEALTH LLC | 4742182e-fdf9-44fe-e063-6394a90adfcc | 2025-12-31 | Warnings | F05Q2T2JA0 |
| Docusate Sodium Liquid | DOCUSATE SODIUM | LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION | 2d8bdd3e-f6e6-43f5-b3b0-e5a882cae41c | 2025-12-31 | Warnings | F05Q2T2JA0 |
| Senna-S | DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG | Walgreens | 36cc3a5b-1891-d39e-e063-6294a90a93b4 | 2025-12-31 | Warnings | F05Q2T2JA0 |
| Docusate Sodium Liquid | DOCUSATE SODIUM | RUGBY LABORATORIES | e21d19d8-6c2d-4474-a663-dfe7e91ac320 | 2025-12-30 | Warnings | F05Q2T2JA0 |
| Senna-S | SENNA-S | Pioneer Life Sciences, LLC | ab46a3ca-6c7a-a81e-e053-2995a90a199f | 2025-12-29 | Warnings | F05Q2T2JA0 |
| Alprazolam | ALPRAZOLAM | Northwind Health Company, LLC | 25174ee5-a86e-ab97-e063-6394a90acd87 | 2025-12-26 | Boxed warning, Warnings, Adverse reactions | 308047 YU55MQ3IZY |
| Senna-S | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | Pharbest Pharmaceuticals, Inc. | 2b5152b2-d354-409f-a19f-b470f4181b3f | 2025-12-24 | Warnings | F05Q2T2JA0 |
| Senna Plus | DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG | CARDINAL HEALTH, 110 DBA LEADER | 4d4101ca-7d78-4712-9b3d-f395f2646c6b | 2025-12-23 | Warnings | F05Q2T2JA0 |
| Senna-S | SENNOSIDES 8.6 MG AND DOCUSATE SODIUM 50 MG | NUVICARE LLC | 9e999e4a-2f72-4a2b-a41b-bdd68bf5a350 | 2025-12-19 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | P & L Development, LLC | cb0765cb-f48e-4daa-97b8-2897a2d95587 | 2025-12-19 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | Strategic Sourcing Services LLC | ba51cca1-b70b-476e-80e6-20cd52292e65 | 2025-12-17 | Warnings | F05Q2T2JA0 |
| Stool Softener Extra Strength | DOCUSATE SODIUM | CVS Pharmacy | a694b4f3-6112-4a1d-a06e-9e5b20fd3d7b | 2025-12-17 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | CARDINAL HEALTH 110, LLC. DBA LEADER 70000 | da5ccd75-8a2f-4f90-ae8a-97d81b8579d2 | 2025-12-17 | Warnings | F05Q2T2JA0 |
| Senna Plus | DOCUSATE SODIUM, SENNOSIDES | CVS Pharmacy | ae9d1672-9ade-4139-9126-5289b87fe574 | 2025-12-17 | Warnings | F05Q2T2JA0 |
| GeriCare Docusate Sodium Liquid | DOCUSATE SODIUM | GERI-CARE PHARMACEUTICALS, CORP | d599ff49-c9a4-401a-a50b-63d89749bbed | 2025-12-11 | Warnings | F05Q2T2JA0 |
| Alprazolam | ALPRAZOLAM | Aurobindo Pharma Limited | d2fd0b3e-9b78-44d0-82a6-96d6c6238750 | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | 197321 308047 197322 308048 YU55MQ3IZY |
| Alprazolam | ALPRAZOLAM | Aurobindo Pharma Limited | 326fa31a-5420-429b-9f7f-170cb38f64bd | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | YU55MQ3IZY |
| Docusate Sodium | DOCUSATE SODIUM | Major Pharmaceuticals | 3e8321cf-7eda-d70c-e063-6394a90a35a5 | 2025-12-10 | Warnings | F05Q2T2JA0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.